nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefazolin—SLC22A11—Methotrexate—germ cell cancer	0.177	0.307	CbGbCtD
Cefazolin—ABCC4—Methotrexate—germ cell cancer	0.165	0.285	CbGbCtD
Cefazolin—SLC22A8—Methotrexate—germ cell cancer	0.103	0.178	CbGbCtD
Cefazolin—SLC22A6—Methotrexate—germ cell cancer	0.0718	0.124	CbGbCtD
Cefazolin—ALB—Methotrexate—germ cell cancer	0.0612	0.106	CbGbCtD
Cefazolin—SLC22A8—choroid plexus—germ cell cancer	0.025	0.169	CbGeAlD
Cefazolin—PON1—blood vessel—germ cell cancer	0.02	0.135	CbGeAlD
Cefazolin—SLC22A8—optic choroid—germ cell cancer	0.0096	0.0647	CbGeAlD
Cefazolin—PON1—bone marrow—germ cell cancer	0.00684	0.0461	CbGeAlD
Cefazolin—SLC22A8—urine—germ cell cancer	0.0067	0.0452	CbGeAlD
Cefazolin—PON1—endocrine gland—germ cell cancer	0.00613	0.0413	CbGeAlD
Cefazolin—PON1—head—germ cell cancer	0.00605	0.0408	CbGeAlD
Cefazolin—Induration—Bleomycin—germ cell cancer	0.00593	0.0242	CcSEcCtD
Cefazolin—Cheilitis—Dactinomycin—germ cell cancer	0.00581	0.0237	CcSEcCtD
Cefazolin—Local reaction—Bleomycin—germ cell cancer	0.00479	0.0195	CcSEcCtD
Cefazolin—Nephropathy—Ifosfamide—germ cell cancer	0.00476	0.0194	CcSEcCtD
Cefazolin—Nephropathy toxic—Bleomycin—germ cell cancer	0.00461	0.0188	CcSEcCtD
Cefazolin—PON1—brain—germ cell cancer	0.00438	0.0295	CbGeAlD
Cefazolin—SLC22A11—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00417	0.147	CbGpPWpGaD
Cefazolin—Induration—Etoposide—germ cell cancer	0.004	0.0163	CcSEcCtD
Cefazolin—Nephropathy toxic—Ifosfamide—germ cell cancer	0.00394	0.0161	CcSEcCtD
Cefazolin—TPMT—trigeminal ganglion—germ cell cancer	0.00376	0.0254	CbGeAlD
Cefazolin—Nephropathy—Etoposide—germ cell cancer	0.00376	0.0153	CcSEcCtD
Cefazolin—TPMT—Metapathway biotransformation—NAT9—germ cell cancer	0.00353	0.125	CbGpPWpGaD
Cefazolin—Nephropathy toxic—Cisplatin—germ cell cancer	0.0034	0.0139	CcSEcCtD
Cefazolin—Anorectal discomfort—Etoposide—germ cell cancer	0.00327	0.0134	CcSEcCtD
Cefazolin—TPMT—retina—germ cell cancer	0.00321	0.0216	CbGeAlD
Cefazolin—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00318	0.112	CbGpPWpGaD
Cefazolin—Nephropathy toxic—Etoposide—germ cell cancer	0.00311	0.0127	CcSEcCtD
Cefazolin—Cholestasis—Ifosfamide—germ cell cancer	0.00298	0.0122	CcSEcCtD
Cefazolin—Tubulointerstitial nephritis—Ifosfamide—germ cell cancer	0.00296	0.0121	CcSEcCtD
Cefazolin—TPMT—telencephalon—germ cell cancer	0.00295	0.0199	CbGeAlD
Cefazolin—TPMT—decidua—germ cell cancer	0.0028	0.0189	CbGeAlD
Cefazolin—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00265	0.0935	CbGpPWpGaD
Cefazolin—Phlebitis—Vinblastine—germ cell cancer	0.00264	0.0108	CcSEcCtD
Cefazolin—TPMT—gonad—germ cell cancer	0.00247	0.0166	CbGeAlD
Cefazolin—TPMT—pituitary gland—germ cell cancer	0.00241	0.0162	CbGeAlD
Cefazolin—TPMT—medulla oblongata—germ cell cancer	0.00232	0.0156	CbGeAlD
Cefazolin—Aplastic anaemia—Dactinomycin—germ cell cancer	0.00232	0.00948	CcSEcCtD
Cefazolin—Nephropathy—Methotrexate—germ cell cancer	0.00225	0.00919	CcSEcCtD
Cefazolin—SLC22A8—trigeminal ganglion—germ cell cancer	0.00224	0.0151	CbGeAlD
Cefazolin—Mouth ulceration—Dactinomycin—germ cell cancer	0.00223	0.00913	CcSEcCtD
Cefazolin—Phlebitis—Bleomycin—germ cell cancer	0.00223	0.00912	CcSEcCtD
Cefazolin—Colitis—Ifosfamide—germ cell cancer	0.00217	0.00888	CcSEcCtD
Cefazolin—TPMT—adrenal gland—germ cell cancer	0.00215	0.0145	CbGeAlD
Cefazolin—TPMT—midbrain—germ cell cancer	0.00212	0.0143	CbGeAlD
Cefazolin—Phlebitis—Dactinomycin—germ cell cancer	0.00208	0.00851	CcSEcCtD
Cefazolin—TPMT—bone marrow—germ cell cancer	0.00208	0.014	CbGeAlD
Cefazolin—TPMT—spinal cord—germ cell cancer	0.00207	0.014	CbGeAlD
Cefazolin—TPMT—female gonad—germ cell cancer	0.002	0.0135	CbGeAlD
Cefazolin—SLC22A11—endocrine gland—germ cell cancer	0.00197	0.0133	CbGeAlD
Cefazolin—SLC22A8—eye—germ cell cancer	0.00193	0.013	CbGeAlD
Cefazolin—Phlebitis—Ifosfamide—germ cell cancer	0.00191	0.00779	CcSEcCtD
Cefazolin—Hepatic function abnormal—Ifosfamide—germ cell cancer	0.00188	0.00768	CcSEcCtD
Cefazolin—Pancytopenia—Vinblastine—germ cell cancer	0.00187	0.00764	CcSEcCtD
Cefazolin—TPMT—endocrine gland—germ cell cancer	0.00186	0.0126	CbGeAlD
Cefazolin—TPMT—head—germ cell cancer	0.00184	0.0124	CbGeAlD
Cefazolin—Haemolytic anaemia—Ifosfamide—germ cell cancer	0.00182	0.00744	CcSEcCtD
Cefazolin—TPMT—testis—germ cell cancer	0.00178	0.012	CbGeAlD
Cefazolin—Candida infection—Etoposide—germ cell cancer	0.00171	0.00697	CcSEcCtD
Cefazolin—Phlebitis—Cisplatin—germ cell cancer	0.00165	0.00672	CcSEcCtD
Cefazolin—TPMT—cerebellum—germ cell cancer	0.00164	0.0111	CbGeAlD
Cefazolin—Agranulocytosis—Vinblastine—germ cell cancer	0.00164	0.00669	CcSEcCtD
Cefazolin—Mouth ulceration—Etoposide—germ cell cancer	0.00162	0.00661	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Dactinomycin—germ cell cancer	0.00162	0.0066	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Dactinomycin—germ cell cancer	0.00162	0.0066	CcSEcCtD
Cefazolin—Haemoglobin—Vinblastine—germ cell cancer	0.00158	0.00647	CcSEcCtD
Cefazolin—Pancytopenia—Bleomycin—germ cell cancer	0.00158	0.00645	CcSEcCtD
Cefazolin—Haemorrhage—Vinblastine—germ cell cancer	0.00158	0.00644	CcSEcCtD
Cefazolin—Liver disorder—Methotrexate—germ cell cancer	0.00157	0.00642	CcSEcCtD
Cefazolin—Haemolytic anaemia—Cisplatin—germ cell cancer	0.00157	0.00641	CcSEcCtD
Cefazolin—Blood creatinine increased—Ifosfamide—germ cell cancer	0.00154	0.00629	CcSEcCtD
Cefazolin—Phlebitis—Etoposide—germ cell cancer	0.00151	0.00616	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Ifosfamide—germ cell cancer	0.00148	0.00605	CcSEcCtD
Cefazolin—Pancytopenia—Dactinomycin—germ cell cancer	0.00147	0.00601	CcSEcCtD
Cefazolin—ABCC4—uterus—germ cell cancer	0.00147	0.00992	CbGeAlD
Cefazolin—Neutropenia—Dactinomycin—germ cell cancer	0.00145	0.00592	CcSEcCtD
Cefazolin—Stomatitis—Bleomycin—germ cell cancer	0.00145	0.0059	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Dactinomycin—germ cell cancer	0.00137	0.0056	CcSEcCtD
Cefazolin—Pancytopenia—Ifosfamide—germ cell cancer	0.00135	0.00551	CcSEcCtD
Cefazolin—Stomatitis—Dactinomycin—germ cell cancer	0.00135	0.0055	CcSEcCtD
Cefazolin—Haemoglobin—Bleomycin—germ cell cancer	0.00134	0.00546	CcSEcCtD
Cefazolin—ALB—adrenal gland—germ cell cancer	0.00133	0.00899	CbGeAlD
Cefazolin—TPMT—brain—germ cell cancer	0.00133	0.00899	CbGeAlD
Cefazolin—Haemorrhage—Bleomycin—germ cell cancer	0.00133	0.00544	CcSEcCtD
Cefazolin—SLC22A6—brain—germ cell cancer	0.00133	0.00895	CbGeAlD
Cefazolin—Blood creatinine increased—Cisplatin—germ cell cancer	0.00133	0.00542	CcSEcCtD
Cefazolin—ABCC4—adrenal gland—germ cell cancer	0.00129	0.00871	CbGeAlD
Cefazolin—Agranulocytosis—Dactinomycin—germ cell cancer	0.00129	0.00527	CcSEcCtD
Cefazolin—TPMT—lymph node—germ cell cancer	0.00129	0.00868	CbGeAlD
Cefazolin—Aspartate aminotransferase increased—Cisplatin—germ cell cancer	0.00128	0.00521	CcSEcCtD
Cefazolin—Anaemia—Vinblastine—germ cell cancer	0.00127	0.00518	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Ifosfamide—germ cell cancer	0.00126	0.00513	CcSEcCtD
Cefazolin—ABCC4—bone marrow—germ cell cancer	0.00125	0.00842	CbGeAlD
Cefazolin—Renal failure—Ifosfamide—germ cell cancer	0.00125	0.00509	CcSEcCtD
Cefazolin—Hepatitis—Dactinomycin—germ cell cancer	0.00124	0.00507	CcSEcCtD
Cefazolin—Stomatitis—Ifosfamide—germ cell cancer	0.00124	0.00504	CcSEcCtD
Cefazolin—Leukopenia—Vinblastine—germ cell cancer	0.00123	0.00501	CcSEcCtD
Cefazolin—ABCC4—female gonad—germ cell cancer	0.0012	0.00812	CbGeAlD
Cefazolin—Convulsion—Vinblastine—germ cell cancer	0.00119	0.00485	CcSEcCtD
Cefazolin—Agranulocytosis—Ifosfamide—germ cell cancer	0.00118	0.00483	CcSEcCtD
Cefazolin—Erythema multiforme—Dactinomycin—germ cell cancer	0.00117	0.00479	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Etoposide—germ cell cancer	0.00117	0.00478	CcSEcCtD
Cefazolin—Pancytopenia—Cisplatin—germ cell cancer	0.00116	0.00475	CcSEcCtD
Cefazolin—Haemoglobin—Ifosfamide—germ cell cancer	0.00114	0.00467	CcSEcCtD
Cefazolin—Haemorrhage—Ifosfamide—germ cell cancer	0.00114	0.00465	CcSEcCtD
Cefazolin—Hepatitis—Ifosfamide—germ cell cancer	0.00114	0.00465	CcSEcCtD
Cefazolin—ABCC4—endocrine gland—germ cell cancer	0.00112	0.00755	CbGeAlD
Cefazolin—ABCC4—head—germ cell cancer	0.00111	0.00745	CbGeAlD
Cefazolin—ALB—testis—germ cell cancer	0.0011	0.00744	CbGeAlD
Cefazolin—SLC22A8—head—germ cell cancer	0.0011	0.00739	CbGeAlD
Cefazolin—Thrombocytopenia—Vinblastine—germ cell cancer	0.0011	0.00448	CcSEcCtD
Cefazolin—Erythema multiforme—Ifosfamide—germ cell cancer	0.00108	0.00439	CcSEcCtD
Cefazolin—Renal failure—Cisplatin—germ cell cancer	0.00107	0.00439	CcSEcCtD
Cefazolin—Vaginal inflammation—Methotrexate—germ cell cancer	0.00107	0.00438	CcSEcCtD
Cefazolin—Anaemia—Bleomycin—germ cell cancer	0.00107	0.00437	CcSEcCtD
Cefazolin—ABCC4—testis—germ cell cancer	0.00107	0.0072	CbGeAlD
Cefazolin—Anorexia—Vinblastine—germ cell cancer	0.00107	0.00436	CcSEcCtD
Cefazolin—Pancytopenia—Etoposide—germ cell cancer	0.00107	0.00435	CcSEcCtD
Cefazolin—Stomatitis—Cisplatin—germ cell cancer	0.00106	0.00435	CcSEcCtD
Cefazolin—Neutropenia—Etoposide—germ cell cancer	0.00105	0.00429	CcSEcCtD
Cefazolin—Leukopenia—Bleomycin—germ cell cancer	0.00104	0.00424	CcSEcCtD
Cefazolin—Vaginal infection—Methotrexate—germ cell cancer	0.00101	0.00413	CcSEcCtD
Cefazolin—Aplastic anaemia—Methotrexate—germ cell cancer	0.00101	0.00411	CcSEcCtD
Cefazolin—Anaemia—Dactinomycin—germ cell cancer	0.000999	0.00408	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Etoposide—germ cell cancer	0.000992	0.00405	CcSEcCtD
Cefazolin—Renal failure—Etoposide—germ cell cancer	0.000984	0.00402	CcSEcCtD
Cefazolin—Stomatitis—Etoposide—germ cell cancer	0.000975	0.00398	CcSEcCtD
Cefazolin—Decreased appetite—Vinblastine—germ cell cancer	0.000973	0.00397	CcSEcCtD
Cefazolin—Mouth ulceration—Methotrexate—germ cell cancer	0.000969	0.00396	CcSEcCtD
Cefazolin—Leukopenia—Dactinomycin—germ cell cancer	0.000967	0.00395	CcSEcCtD
Cefazolin—Pain—Vinblastine—germ cell cancer	0.000957	0.00391	CcSEcCtD
Cefazolin—Confusional state—Bleomycin—germ cell cancer	0.000953	0.00389	CcSEcCtD
Cefazolin—Anaphylactic shock—Bleomycin—germ cell cancer	0.000946	0.00386	CcSEcCtD
Cefazolin—Agranulocytosis—Etoposide—germ cell cancer	0.000934	0.00381	CcSEcCtD
Cefazolin—Thrombocytopenia—Bleomycin—germ cell cancer	0.000926	0.00378	CcSEcCtD
Cefazolin—Feeling abnormal—Vinblastine—germ cell cancer	0.000923	0.00377	CcSEcCtD
Cefazolin—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000916	0.00374	CcSEcCtD
Cefazolin—Anaemia—Ifosfamide—germ cell cancer	0.000915	0.00374	CcSEcCtD
Cefazolin—Agitation—Ifosfamide—germ cell cancer	0.00091	0.00372	CcSEcCtD
Cefazolin—Anorexia—Bleomycin—germ cell cancer	0.000901	0.00368	CcSEcCtD
Cefazolin—Leukopenia—Ifosfamide—germ cell cancer	0.000886	0.00362	CcSEcCtD
Cefazolin—Abdominal pain—Vinblastine—germ cell cancer	0.000885	0.00361	CcSEcCtD
Cefazolin—Hypotension—Bleomycin—germ cell cancer	0.000884	0.00361	CcSEcCtD
Cefazolin—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000863	0.00353	CcSEcCtD
Cefazolin—Convulsion—Ifosfamide—germ cell cancer	0.000858	0.0035	CcSEcCtD
Cefazolin—Erythema multiforme—Etoposide—germ cell cancer	0.000849	0.00347	CcSEcCtD
Cefazolin—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000847	0.0299	CbGpPWpGaD
Cefazolin—Flatulence—Cisplatin—germ cell cancer	0.000841	0.00344	CcSEcCtD
Cefazolin—Anorexia—Dactinomycin—germ cell cancer	0.000841	0.00343	CcSEcCtD
Cefazolin—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000835	0.0294	CbGpPWpGaD
Cefazolin—ALB—brain—germ cell cancer	0.000828	0.00558	CbGeAlD
Cefazolin—Hypersensitivity—Vinblastine—germ cell cancer	0.000825	0.00337	CcSEcCtD
Cefazolin—Decreased appetite—Bleomycin—germ cell cancer	0.000822	0.00336	CcSEcCtD
Cefazolin—Confusional state—Ifosfamide—germ cell cancer	0.000815	0.00333	CcSEcCtD
Cefazolin—Pain—Bleomycin—germ cell cancer	0.000809	0.0033	CcSEcCtD
Cefazolin—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000808	0.0033	CcSEcCtD
Cefazolin—Asthenia—Vinblastine—germ cell cancer	0.000803	0.00328	CcSEcCtD
Cefazolin—ABCC4—brain—germ cell cancer	0.000801	0.0054	CbGeAlD
Cefazolin—ALB—lymph node—germ cell cancer	0.0008	0.00539	CbGeAlD
Cefazolin—SLC22A8—brain—germ cell cancer	0.000795	0.00536	CbGeAlD
Cefazolin—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000791	0.00323	CcSEcCtD
Cefazolin—Anaemia—Cisplatin—germ cell cancer	0.000789	0.00322	CcSEcCtD
Cefazolin—Feeling abnormal—Bleomycin—germ cell cancer	0.000779	0.00318	CcSEcCtD
Cefazolin—ABCC4—lymph node—germ cell cancer	0.000774	0.00522	CbGeAlD
Cefazolin—Anorexia—Ifosfamide—germ cell cancer	0.00077	0.00315	CcSEcCtD
Cefazolin—Decreased appetite—Dactinomycin—germ cell cancer	0.000767	0.00313	CcSEcCtD
Cefazolin—Diarrhoea—Vinblastine—germ cell cancer	0.000766	0.00313	CcSEcCtD
Cefazolin—Leukopenia—Cisplatin—germ cell cancer	0.000764	0.00312	CcSEcCtD
Cefazolin—Fatigue—Dactinomycin—germ cell cancer	0.00076	0.0031	CcSEcCtD
Cefazolin—Hypotension—Ifosfamide—germ cell cancer	0.000755	0.00308	CcSEcCtD
Cefazolin—Pain—Dactinomycin—germ cell cancer	0.000754	0.00308	CcSEcCtD
Cefazolin—Urticaria—Bleomycin—germ cell cancer	0.000751	0.00307	CcSEcCtD
Cefazolin—Body temperature increased—Bleomycin—germ cell cancer	0.000748	0.00305	CcSEcCtD
Cefazolin—Dizziness—Vinblastine—germ cell cancer	0.00074	0.00302	CcSEcCtD
Cefazolin—Convulsion—Cisplatin—germ cell cancer	0.00074	0.00302	CcSEcCtD
Cefazolin—ALB—Transport of organic anions—AVP—germ cell cancer	0.000738	0.026	CbGpPWpGaD
Cefazolin—Feeling abnormal—Dactinomycin—germ cell cancer	0.000727	0.00297	CcSEcCtD
Cefazolin—Anaemia—Etoposide—germ cell cancer	0.000723	0.00295	CcSEcCtD
Cefazolin—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000721	0.00294	CcSEcCtD
Cefazolin—Somnolence—Ifosfamide—germ cell cancer	0.000718	0.00293	CcSEcCtD
Cefazolin—Vomiting—Vinblastine—germ cell cancer	0.000712	0.00291	CcSEcCtD
Cefazolin—Decreased appetite—Ifosfamide—germ cell cancer	0.000703	0.00287	CcSEcCtD
Cefazolin—ABCC4—Platelet degranulation—CD9—germ cell cancer	0.000702	0.0248	CbGpPWpGaD
Cefazolin—Headache—Vinblastine—germ cell cancer	0.000701	0.00286	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.0007	0.00286	CcSEcCtD
Cefazolin—Leukopenia—Etoposide—germ cell cancer	0.0007	0.00286	CcSEcCtD
Cefazolin—Abdominal pain—Dactinomycin—germ cell cancer	0.000697	0.00285	CcSEcCtD
Cefazolin—Body temperature increased—Dactinomycin—germ cell cancer	0.000697	0.00285	CcSEcCtD
Cefazolin—Fatigue—Ifosfamide—germ cell cancer	0.000697	0.00285	CcSEcCtD
Cefazolin—Anaphylactic shock—Cisplatin—germ cell cancer	0.000697	0.00285	CcSEcCtD
Cefazolin—Hypersensitivity—Bleomycin—germ cell cancer	0.000697	0.00284	CcSEcCtD
Cefazolin—Pain—Ifosfamide—germ cell cancer	0.000691	0.00282	CcSEcCtD
Cefazolin—Loss of consciousness—Etoposide—germ cell cancer	0.000687	0.00281	CcSEcCtD
Cefazolin—Thrombocytopenia—Cisplatin—germ cell cancer	0.000682	0.00279	CcSEcCtD
Cefazolin—Asthenia—Bleomycin—germ cell cancer	0.000678	0.00277	CcSEcCtD
Cefazolin—Convulsion—Etoposide—germ cell cancer	0.000678	0.00277	CcSEcCtD
Cefazolin—Pruritus—Bleomycin—germ cell cancer	0.000669	0.00273	CcSEcCtD
Cefazolin—ABCC4—Response to elevated platelet cytosolic Ca2+—CD9—germ cell cancer	0.000669	0.0236	CbGpPWpGaD
Cefazolin—Feeling abnormal—Ifosfamide—germ cell cancer	0.000666	0.00272	CcSEcCtD
Cefazolin—Eosinophilia—Methotrexate—germ cell cancer	0.000666	0.00272	CcSEcCtD
Cefazolin—Nausea—Vinblastine—germ cell cancer	0.000665	0.00272	CcSEcCtD
Cefazolin—Anorexia—Cisplatin—germ cell cancer	0.000664	0.00271	CcSEcCtD
Cefazolin—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000661	0.0027	CcSEcCtD
Cefazolin—Hypotension—Cisplatin—germ cell cancer	0.000651	0.00266	CcSEcCtD
Cefazolin—Hypersensitivity—Dactinomycin—germ cell cancer	0.00065	0.00265	CcSEcCtD
Cefazolin—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000646	0.0228	CbGpPWpGaD
Cefazolin—Confusional state—Etoposide—germ cell cancer	0.000644	0.00263	CcSEcCtD
Cefazolin—Urticaria—Ifosfamide—germ cell cancer	0.000642	0.00262	CcSEcCtD
Cefazolin—Abdominal pain—Ifosfamide—germ cell cancer	0.000639	0.00261	CcSEcCtD
Cefazolin—Body temperature increased—Ifosfamide—germ cell cancer	0.000639	0.00261	CcSEcCtD
Cefazolin—Pancytopenia—Methotrexate—germ cell cancer	0.000638	0.00261	CcSEcCtD
Cefazolin—Anaphylactic shock—Etoposide—germ cell cancer	0.000638	0.00261	CcSEcCtD
Cefazolin—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000637	0.0225	CbGpPWpGaD
Cefazolin—Asthenia—Dactinomycin—germ cell cancer	0.000633	0.00258	CcSEcCtD
Cefazolin—Neutropenia—Methotrexate—germ cell cancer	0.000629	0.00257	CcSEcCtD
Cefazolin—Thrombocytopenia—Etoposide—germ cell cancer	0.000625	0.00255	CcSEcCtD
Cefazolin—Anorexia—Etoposide—germ cell cancer	0.000608	0.00248	CcSEcCtD
Cefazolin—Decreased appetite—Cisplatin—germ cell cancer	0.000606	0.00247	CcSEcCtD
Cefazolin—Diarrhoea—Dactinomycin—germ cell cancer	0.000603	0.00246	CcSEcCtD
Cefazolin—Vomiting—Bleomycin—germ cell cancer	0.000601	0.00246	CcSEcCtD
Cefazolin—Hypotension—Etoposide—germ cell cancer	0.000596	0.00244	CcSEcCtD
Cefazolin—Rash—Bleomycin—germ cell cancer	0.000596	0.00243	CcSEcCtD
Cefazolin—Pain—Cisplatin—germ cell cancer	0.000596	0.00243	CcSEcCtD
Cefazolin—Dermatitis—Bleomycin—germ cell cancer	0.000596	0.00243	CcSEcCtD
Cefazolin—Hypersensitivity—Ifosfamide—germ cell cancer	0.000595	0.00243	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000594	0.00243	CcSEcCtD
Cefazolin—Renal failure—Methotrexate—germ cell cancer	0.000589	0.00241	CcSEcCtD
Cefazolin—Stomatitis—Methotrexate—germ cell cancer	0.000584	0.00239	CcSEcCtD
Cefazolin—Asthenia—Ifosfamide—germ cell cancer	0.00058	0.00237	CcSEcCtD
Cefazolin—Feeling abnormal—Cisplatin—germ cell cancer	0.000574	0.00234	CcSEcCtD
Cefazolin—Pruritus—Ifosfamide—germ cell cancer	0.000572	0.00233	CcSEcCtD
Cefazolin—Somnolence—Etoposide—germ cell cancer	0.000567	0.00232	CcSEcCtD
Cefazolin—Nausea—Bleomycin—germ cell cancer	0.000562	0.00229	CcSEcCtD
Cefazolin—Vomiting—Dactinomycin—germ cell cancer	0.000561	0.00229	CcSEcCtD
Cefazolin—Agranulocytosis—Methotrexate—germ cell cancer	0.000559	0.00228	CcSEcCtD
Cefazolin—Rash—Dactinomycin—germ cell cancer	0.000556	0.00227	CcSEcCtD
Cefazolin—Decreased appetite—Etoposide—germ cell cancer	0.000555	0.00227	CcSEcCtD
Cefazolin—Diarrhoea—Ifosfamide—germ cell cancer	0.000553	0.00226	CcSEcCtD
Cefazolin—Body temperature increased—Cisplatin—germ cell cancer	0.000551	0.00225	CcSEcCtD
Cefazolin—Fatigue—Etoposide—germ cell cancer	0.00055	0.00225	CcSEcCtD
Cefazolin—Pain—Etoposide—germ cell cancer	0.000546	0.00223	CcSEcCtD
Cefazolin—Haemoglobin—Methotrexate—germ cell cancer	0.000541	0.00221	CcSEcCtD
Cefazolin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000539	0.019	CbGpPWpGaD
Cefazolin—Haemorrhage—Methotrexate—germ cell cancer	0.000538	0.0022	CcSEcCtD
Cefazolin—Hepatitis—Methotrexate—germ cell cancer	0.000538	0.0022	CcSEcCtD
Cefazolin—Dizziness—Ifosfamide—germ cell cancer	0.000534	0.00218	CcSEcCtD
Cefazolin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000531	0.0187	CbGpPWpGaD
Cefazolin—Feeling abnormal—Etoposide—germ cell cancer	0.000526	0.00215	CcSEcCtD
Cefazolin—Nausea—Dactinomycin—germ cell cancer	0.000524	0.00214	CcSEcCtD
Cefazolin—Gastrointestinal pain—Etoposide—germ cell cancer	0.000522	0.00213	CcSEcCtD
Cefazolin—Vomiting—Ifosfamide—germ cell cancer	0.000514	0.0021	CcSEcCtD
Cefazolin—Hypersensitivity—Cisplatin—germ cell cancer	0.000513	0.0021	CcSEcCtD
Cefazolin—Rash—Ifosfamide—germ cell cancer	0.00051	0.00208	CcSEcCtD
Cefazolin—Dermatitis—Ifosfamide—germ cell cancer	0.000509	0.00208	CcSEcCtD
Cefazolin—Erythema multiforme—Methotrexate—germ cell cancer	0.000509	0.00208	CcSEcCtD
Cefazolin—Urticaria—Etoposide—germ cell cancer	0.000507	0.00207	CcSEcCtD
Cefazolin—Abdominal pain—Etoposide—germ cell cancer	0.000505	0.00206	CcSEcCtD
Cefazolin—Body temperature increased—Etoposide—germ cell cancer	0.000505	0.00206	CcSEcCtD
Cefazolin—Asthenia—Cisplatin—germ cell cancer	0.0005	0.00204	CcSEcCtD
Cefazolin—Nausea—Ifosfamide—germ cell cancer	0.00048	0.00196	CcSEcCtD
Cefazolin—Diarrhoea—Cisplatin—germ cell cancer	0.000477	0.00195	CcSEcCtD
Cefazolin—Hypersensitivity—Etoposide—germ cell cancer	0.00047	0.00192	CcSEcCtD
Cefazolin—Asthenia—Etoposide—germ cell cancer	0.000458	0.00187	CcSEcCtD
Cefazolin—Pruritus—Etoposide—germ cell cancer	0.000452	0.00184	CcSEcCtD
Cefazolin—ABCC4—NRF2 pathway—SLC2A3—germ cell cancer	0.000447	0.0158	CbGpPWpGaD
Cefazolin—Vomiting—Cisplatin—germ cell cancer	0.000443	0.00181	CcSEcCtD
Cefazolin—Rash—Cisplatin—germ cell cancer	0.000439	0.00179	CcSEcCtD
Cefazolin—Dermatitis—Cisplatin—germ cell cancer	0.000439	0.00179	CcSEcCtD
Cefazolin—Diarrhoea—Etoposide—germ cell cancer	0.000437	0.00178	CcSEcCtD
Cefazolin—Anaemia—Methotrexate—germ cell cancer	0.000433	0.00177	CcSEcCtD
Cefazolin—Dizziness—Etoposide—germ cell cancer	0.000422	0.00172	CcSEcCtD
Cefazolin—Leukopenia—Methotrexate—germ cell cancer	0.000419	0.00171	CcSEcCtD
Cefazolin—Nausea—Cisplatin—germ cell cancer	0.000414	0.00169	CcSEcCtD
Cefazolin—Convulsion—Methotrexate—germ cell cancer	0.000406	0.00166	CcSEcCtD
Cefazolin—Vomiting—Etoposide—germ cell cancer	0.000406	0.00166	CcSEcCtD
Cefazolin—Rash—Etoposide—germ cell cancer	0.000402	0.00164	CcSEcCtD
Cefazolin—Dermatitis—Etoposide—germ cell cancer	0.000402	0.00164	CcSEcCtD
Cefazolin—Headache—Etoposide—germ cell cancer	0.0004	0.00163	CcSEcCtD
Cefazolin—Confusional state—Methotrexate—germ cell cancer	0.000385	0.00157	CcSEcCtD
Cefazolin—SLC22A11—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000385	0.0136	CbGpPWpGaD
Cefazolin—Anaphylactic shock—Methotrexate—germ cell cancer	0.000382	0.00156	CcSEcCtD
Cefazolin—SLC22A11—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000379	0.0134	CbGpPWpGaD
Cefazolin—Nausea—Etoposide—germ cell cancer	0.000379	0.00155	CcSEcCtD
Cefazolin—Thrombocytopenia—Methotrexate—germ cell cancer	0.000374	0.00153	CcSEcCtD
Cefazolin—ABCC4—Ectoderm Differentiation—SOX2—germ cell cancer	0.000366	0.0129	CbGpPWpGaD
Cefazolin—Anorexia—Methotrexate—germ cell cancer	0.000364	0.00149	CcSEcCtD
Cefazolin—Hypotension—Methotrexate—germ cell cancer	0.000357	0.00146	CcSEcCtD
Cefazolin—Somnolence—Methotrexate—germ cell cancer	0.00034	0.00139	CcSEcCtD
Cefazolin—Dyspepsia—Methotrexate—germ cell cancer	0.000337	0.00137	CcSEcCtD
Cefazolin—Decreased appetite—Methotrexate—germ cell cancer	0.000332	0.00136	CcSEcCtD
Cefazolin—Fatigue—Methotrexate—germ cell cancer	0.00033	0.00135	CcSEcCtD
Cefazolin—Pain—Methotrexate—germ cell cancer	0.000327	0.00134	CcSEcCtD
Cefazolin—ALB—Platelet degranulation—CD9—germ cell cancer	0.000318	0.0112	CbGpPWpGaD
Cefazolin—Feeling abnormal—Methotrexate—germ cell cancer	0.000315	0.00129	CcSEcCtD
Cefazolin—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000313	0.00128	CcSEcCtD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—CD9—germ cell cancer	0.000311	0.011	CbGpPWpGaD
Cefazolin—Urticaria—Methotrexate—germ cell cancer	0.000304	0.00124	CcSEcCtD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—CD9—germ cell cancer	0.000303	0.0107	CbGpPWpGaD
Cefazolin—Abdominal pain—Methotrexate—germ cell cancer	0.000302	0.00123	CcSEcCtD
Cefazolin—Body temperature increased—Methotrexate—germ cell cancer	0.000302	0.00123	CcSEcCtD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000299	0.0105	CbGpPWpGaD
Cefazolin—SLC22A8—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000294	0.0104	CbGpPWpGaD
Cefazolin—SLC22A8—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000289	0.0102	CbGpPWpGaD
Cefazolin—Hypersensitivity—Methotrexate—germ cell cancer	0.000282	0.00115	CcSEcCtD
Cefazolin—Asthenia—Methotrexate—germ cell cancer	0.000274	0.00112	CcSEcCtD
Cefazolin—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	0.000274	0.00965	CbGpPWpGaD
Cefazolin—Pruritus—Methotrexate—germ cell cancer	0.00027	0.0011	CcSEcCtD
Cefazolin—Diarrhoea—Methotrexate—germ cell cancer	0.000262	0.00107	CcSEcCtD
Cefazolin—Dizziness—Methotrexate—germ cell cancer	0.000253	0.00103	CcSEcCtD
Cefazolin—SLC22A6—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000245	0.00864	CbGpPWpGaD
Cefazolin—Vomiting—Methotrexate—germ cell cancer	0.000243	0.000993	CcSEcCtD
Cefazolin—SLC22A6—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000241	0.00851	CbGpPWpGaD
Cefazolin—Rash—Methotrexate—germ cell cancer	0.000241	0.000984	CcSEcCtD
Cefazolin—Dermatitis—Methotrexate—germ cell cancer	0.000241	0.000983	CcSEcCtD
Cefazolin—Headache—Methotrexate—germ cell cancer	0.00024	0.000978	CcSEcCtD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000228	0.00805	CbGpPWpGaD
Cefazolin—Nausea—Methotrexate—germ cell cancer	0.000227	0.000927	CcSEcCtD
Cefazolin—ABCC4—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000219	0.00771	CbGpPWpGaD
Cefazolin—ABCC4—Fluoropyrimidine Activity—TP53—germ cell cancer	0.000214	0.00753	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000196	0.0069	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000193	0.0068	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.00019	0.00671	CbGpPWpGaD
Cefazolin—SLC22A11—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000178	0.00626	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—SLC2A3—germ cell cancer	0.000166	0.00587	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—SLC22A3—germ cell cancer	0.000164	0.00578	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—CD9—germ cell cancer	0.00016	0.00566	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000149	0.00526	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000147	0.00518	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000143	0.00505	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000141	0.00497	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—CD9—germ cell cancer	0.000141	0.00497	CbGpPWpGaD
Cefazolin—SLC22A8—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000135	0.00478	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—CRABP1—germ cell cancer	0.000134	0.00471	CbGpPWpGaD
Cefazolin—ALB—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000127	0.00449	CbGpPWpGaD
Cefazolin—ALB—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000126	0.00443	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000125	0.00439	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000123	0.00433	CbGpPWpGaD
Cefazolin—SLC22A6—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000113	0.00399	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	9.9e-05	0.00349	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—AVP—germ cell cancer	9.03e-05	0.00318	CbGpPWpGaD
Cefazolin—ABCC4—Ectoderm Differentiation—MYC—germ cell cancer	8.28e-05	0.00292	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CD9—germ cell cancer	7.26e-05	0.00256	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—AVP—germ cell cancer	6.88e-05	0.00243	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—AVP—germ cell cancer	6.6e-05	0.00233	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	6.47e-05	0.00228	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	6.38e-05	0.00225	CbGpPWpGaD
Cefazolin—ALB—SLC-mediated transmembrane transport—AVP—germ cell cancer	5.88e-05	0.00207	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—AVP—germ cell cancer	5.74e-05	0.00203	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—TP53—germ cell cancer	5.55e-05	0.00196	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	5.47e-05	0.00193	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SLC2A3—germ cell cancer	3.03e-05	0.00107	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SLC22A3—germ cell cancer	2.99e-05	0.00105	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—AVP—germ cell cancer	2.99e-05	0.00105	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CRABP1—germ cell cancer	2.44e-05	0.000859	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—TP53—germ cell cancer	2.4e-05	0.000848	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—HRAS—germ cell cancer	2.3e-05	0.000811	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—TP53—germ cell cancer	1.09e-05	0.000384	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—HRAS—germ cell cancer	1.04e-05	0.000367	CbGpPWpGaD
